Related Experiment Video

Updated: Jul 14, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients

S K Sedimbi1, X R Luo, C B Sanjeevi

  • 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Genes and Immunity
|June 8, 2007
PubMed

Insights

The SUMO4 M55V gene variant is not linked to type 1 diabetes (TIDM) susceptibility alone in Caucasians. However, it modifies TIDM risk when interacting with specific human leukocyte antigen (HLA) variants.

Area of Science:

  • Genetics
  • Immunology
  • Endocrinology

Background:

  • The SUMO4 M55V gene variant's association with type 1 diabetes (TIDM) is debated, particularly its differing prevalence in Asian versus Caucasian populations.
  • Previous studies suggest a potential link between SUMO4 M55V and TIDM, but its independent role and interaction with other genetic factors require further investigation.

Purpose of the Study:

  • To investigate the association of the SUMO4 M55V polymorphism with TIDM in a large Swedish Caucasian cohort.
  • To examine the interaction between SUMO4 M55V and human leukocyte antigen (HLA) class II molecules in TIDM susceptibility.

Main Methods:

  • A case-control study involving 673 TIDM patients and 535 healthy controls from Sweden.
  • Genotyping of the SUMO4 M55V variant and analysis of human leukocyte antigen (HLA) class II alleles using PCR-RFLP.

Main Results:

  • The SUMO4 M55V polymorphism, independently, showed no significant association with TIDM susceptibility in the studied Caucasian cohort.
  • A significant interaction was observed: the SUMO4 GG genotype increased TIDM risk in individuals with HLA-DR3/DR4, while the SUMO4 AA genotype decreased this risk.

Conclusions:

  • SUMO4 M55V is not an independent risk factor for TIDM in Caucasians.
  • The M55V variant of SUMO4 modulates TIDM risk in conjunction with high-risk HLA-DR3 and HLA-DR4 alleles, highlighting gene-gene interactions in TIDM pathogenesis.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...